Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00387400
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2006-10-12
Brief Title:
Temozolomide Everolimus in Newly Diagnosed Recurrent or Progressive Malignant Glioblastoma Multiforme
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Organization Data
Organization:
Canadian Cancer Trials Group
Class:
NETWORK
Study ID:
I162
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NCIC Clinical Trials Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None